Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • PlastiWorld 2026 Concludes with 800+ MoUs, Accelerating India’s Push Toward $50 Billion Export Target Business
  • Having Experienced The Corporate Life’s Exhaustion First-hand, Bajan Bopanna Brings Visitors To The Lap Of Nature With Evergreen County Business
  • Assurance Intl Ltd Extends Its Licensing With Goodyear, Introducing New Categories In Auto Parts, Car Care Products And Car Accessories Business
  • Unveiling the Remarkable Journey of Sudhir Kove: A Tale of Triumph, Transformation, and Transcendence Business
  • A hilarious antidote to the pandemic gloom: The book What The Pandemic Learned From Me launched worldwide Business
  • Dr Mohammed Khan Received the 14th Bharat Ratna Dr A P J Abdul Kalam Award 2022 Lifestyle
  • Veer Energy & Infrastructure to consider Bonus Issue Business
  • Sandeep Sheoran Crowned India’s Strongest Armwrestler at 5th National Armwrest Sports

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Is Bypass Surgery for Heart Patients Avoidable? Double complex CTO angioplasty & stenting by Radial approach made it possible to avoid bypass surgery English
  • GenWorks Advocates For Tackling Cardiovascular Diseases On World Heart Day Health
  • My Health, My Right: Suggestions from Leading Health Experts on World Health Day 2024 Health
  • PillUp’s Innovative PillUP Sure Tackles Fake Medicines, Ensuring Authenticity and Better Health Health
  • CityPlus Hospital Sets New Milestone with Robotic Total Knee Replacement Surgery Led by Dr. Rohit Damor Health
  • Sreekanth Erepalli: Pioneering Tradition and Innovation in field of Ayurveda and Herbal Cosmetics Health

Recent Posts

  • SCMS Bengaluru BBA Admissions 2026: SET Registration Closed on April 15; SCMS Bengaluru BBA Application Deadline May 21, 2026
  • Sarvajanik University Introduces Liberal Arts Programmes to build Analytical, Research and Human-Centric Leaders
  • Bajaj General Insurance Launches MHCP EDGE Plus, a Flexible, Next-Generation Health Indemnity Plan with Coverage upto INR 5 Crores
  • Parul University Unveils Lakshya 2047: Center for Future Skills, An Ecosystem with Futuristic Labs and Highly Advanced Infrastructure
  • Resonance’s Student M. Rushi: Ranks 1st in TG EAPCET 2026

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • TiE Women Global Pitch Competition 2022 organised by TiE Surat Business
  • Critical Care Ambulance from Goldiam International made a difference at Mumbai’s largest Durga Puja Pandal Business
  • 82% of students of grades 11 and 12 consider career counseling in schools an imperative: 2021IC3 Institute Student Quest Survey Press Release
  • Vedant Newatia to sway Indian fine dining in Michelin star style Business
  • 5th Edition of 3D GEM 2025 Showcases India’s Leadership in 3D Printing & 3D Visualisation at IISc Bengaluru Press Release
  • PIPL Plans to Go Pan-India Looking at Business Growth Business
  • Sri Chima Group of Industries Celebrates 30 Years of Excellence and Dedication across Diverse Industries Business
  • Fastag Recharge Online: How to Recharge Fastag Lifestyle

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme